title: Impact of formulary restrictions on patient safety.
authors.affiliation: Clinical Research, AstraZeneca Pharmaceuticals, Wilmington, DE, USA. arthur.lazarus@astrazeneca.com
authors.forename: Arthur
authors.initials: A
authors.lastname: Lazarus
mesh_terms: D005569:Formularies as Topic; D008329:Managed Care Programs; D010818:Practice Patterns, Physicians'; D011787:Quality of Health Care; D017751:Safety Management; D014481:United States